Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E306.13 EPS (ttm)0.11 Insider Own2.70% Shs Outstand1.01B Perf Week0.06%
Market Cap32.77B Forward P/E6.90 EPS next Y4.70 Insider Trans0.00% Shs Float912.42M Perf Month0.90%
Income78.00M PEG348.67 EPS next Q1.08 Inst Own59.10% Short Float4.16% Perf Quarter2.27%
Sales22.72B P/S1.44 EPS this Y-96.10% Inst Trans-0.08% Short Ratio4.88 Perf Half Y-4.36%
Book/sh29.92 P/B1.08 EPS next Y-0.88% ROA0.10% Target Price36.91 Perf Year-41.17%
Cash/sh0.90 P/C35.94 EPS next 5Y0.88% ROE0.30% 52W Range27.59 - 55.79 Perf YTD-10.48%
Dividend1.36 P/FCF16.02 EPS past 5Y-53.00% ROI1.10% 52W High-41.84% Beta0.46
Dividend %4.19% Quick Ratio0.60 Sales past 5Y3.60% Gross Margin52.30% 52W Low17.59% ATR0.83
Employees56960 Current Ratio0.90 Sales Q/Q17.00% Oper. Margin8.30% RSI (14)56.39 Volatility1.86% 2.62%
OptionableYes Debt/Eq1.14 EPS Q/Q-8.00% Profit Margin0.30% Rel Volume0.94 Prev Close33.04
ShortableYes LT Debt/Eq1.08 EarningsAug 03 BMO Payout- Avg Volume7.78M Price32.45
Recom2.50 SMA200.38% SMA504.71% SMA200-5.97% Volume7,325,836 Change-1.79%
Jul-17-17Reiterated RBC Capital Mkts Outperform $38 → $37
Jun-16-17Upgrade Mizuho Neutral → Buy $25 → $30
Jun-16-17Initiated Cantor Fitzgerald Neutral $31
Feb-28-17Downgrade Argus Buy → Hold
Feb-13-17Reiterated Maxim Group Hold $41 → $40
Feb-10-17Downgrade Mizuho Buy → Neutral $40 → $27
Jan-31-17Upgrade BofA/Merrill Neutral → Buy
Jan-31-17Reiterated Barclays Equal Weight $46 → $38
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-06-17Downgrade Maxim Group Buy → Hold $49 → $41
Jan-03-17Reiterated Maxim Group Buy $52 → $49
Dec-07-16Resumed Oppenheimer Outperform
Nov-16-16Reiterated RBC Capital Mkts Outperform $58 → $51
Nov-16-16Reiterated Mizuho Neutral $45 → $40
Nov-16-16Reiterated Maxim Group Buy $72 → $52
Nov-16-16Reiterated Deutsche Bank Buy $68 → $54
Nov-16-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-16-16Downgrade Jefferies Buy → Hold $69 → $40
Nov-14-16Resumed Barclays Equal Weight $46
Jul-27-17 12:55PM  [$$] AstraZeneca shares tumble 15% on big drug trial setback Financial Times
12:24PM  [$$] AstraZeneca: transcendental agitation Financial Times
10:51AM  Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis TheStreet.com
10:05AM  [$$] McCaskill Expands Probe Into Opioid Addiction Crisis The Wall Street Journal
07:52AM  Ignore the Obamacare fight in Congress and buy these 5 health-care stocks MarketWatch
Jul-26-17 08:55AM  Major Pharma Short Interest Takes a Big Step Back 24/7 Wall St.
Jul-25-17 04:25PM  Inside GlaxoSmithKlines 2Q17 Earnings Estimates Market Realist
Jul-24-17 02:51PM  Teva Announces the Launch of Generic Vagifem® in the United States Business Wire
Jul-23-17 06:38AM  Teva Pharm to reduce workforce in Israel, mainly in production Reuters
Jul-21-17 06:45PM  Stull, Stull & Brody Announces Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of American Depository Shares of Teva Pharmaceutical Industries Limited GlobeNewswire
01:15PM  7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods TheStreet.com
03:28AM  AstraZeneca CEO reassures staff, aims to be at September cancer meet Reuters
Jul-20-17 04:38PM  Mount Vernon Associates Inc Buys Energy Transfer Partners LP, Teva Pharmaceutical Industries GuruFocus.com
05:00AM  NICE Recommends CINQAERO® (reslizumab) for the Treatment of Severe Eosinophilic Asthma Business Wire
Jul-17-17 05:47PM  AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise Zacks
02:00PM  [$$] EU accuses Teva Pharmaceutical of anti-competitive behaviour Financial Times
01:55PM  U.S. court upholds Takeda patent on cancer drug Velcade Reuters
11:41AM  Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back InvestorPlace
11:30AM  Valeant Unloads Yet Another Unit Barrons.com
07:36AM  EU regulators charge Teva over pay-for-delay drug deal Reuters
07:34AM  EU regulators charge Teva over pay-for-delay drug deal Reuters
03:36AM  AstraZeneca Shares Top FTSE 100 After Drugmaker Says CEO Will Host Late-July Earnings Call TheStreet.com
Jul-14-17 09:45PM  Here Are The 5 Stories Europe Was Talking About This Week TheStreet.com
06:19PM  [$$] AstraZeneca CEO's Future Remains Shrouded in Mystery The Wall Street Journal
05:47PM  [$$] Pascal Soriot to remain at AstraZeneca Financial Times
04:45PM  Why Cyberark Software Ltd (CYBR), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Wynn Resorts, Limited (WYNN) Are 3 of Todays Worst Stocks InvestorPlace
04:42PM  AstraZeneca Pops On Report CEO Won't Jump Ship For Teva Pharma Investor's Business Daily
04:05PM  Potential AstraZeneca C-Suite Shuffle Rekindles Takeover Chatter TheStreet.com
08:22AM  Valeant Pharmaceuticals Overall Trajectory Remains on Edge, Teva Pharmaceutical May Face Difficulty Beating Consensus SmarterAnalyst
12:34AM  [$$] Mystery at AstraZeneca: Is CEO Pascal Soriot Staying or Going? The Wall Street Journal
Jul-13-17 04:15PM  Why AstraZeneca's Rumored Chief Executive Exit Is Bad Timing Investor's Business Daily
04:14PM  Will AstraZeneca's CEO Leave for Teva? Credit Suisse Doesn't Think So TheStreet.com
02:49PM  Airlines, pharma, financials & more in the blitz CNBC Videos
01:04PM  [$$] AstraZeneca shares hit by report on chief's departure Financial Times
01:01PM  Will AstraZeneca's CEO Leave For Teva? Barrons.com
11:45AM  Report: AstraZeneca CEO in running for Teva chief executive job American City Business Journals
11:38AM  Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders Business Wire
09:20AM  Major Pharma Short Sellers Become More Selective 24/7 Wall St.
07:52AM  Early movers: DAL, TGT, YNDX, STX, SNAP, AZN, TRNC, AAL & more CNBC
07:07AM  AstraZeneca Falls After Report Says Its CEO Is Leaving for Teva Investopedia
05:11AM  AstraZeneca slumps on report CEO is heading to Teva Reuters
03:51AM  AstraZeneca Shares Slump On Reports Teva Courting CEO Pascal Soriot TheStreet.com
Jul-12-17 04:03PM  Teva Stock Jumps as New CEO Expected to Be Named TheStreet.com
03:47PM  AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report Reuters
03:18PM  AstraZeneca's CEO Soriot to join Israeli drugs company Teva-report Reuters
Jul-11-17 10:00AM  Teva to Report Second Quarter 2017 Financial Results on August 3, 2017 Business Wire
08:00AM  Teva and the Huntington Study Group Announce Publication of Data for AUSTEDO (deutetrabenazine) Tablets in Huntington Disease from ARC-HD Study in JAMA Neurology Business Wire
06:00AM  5 Top Stocks for July Motley Fool
Jul-10-17 09:14AM  Lilly Gets Favorable Ruling in Alimta Patent Lawsuit in UK Zacks
12:29AM  [$$] U.K. Court Says Generics Infringe on Lillys Alimta Patents The Wall Street Journal
Jul-08-17 10:44AM  Two cancer drug prices have already been hiked by 8% this year MarketWatch
Jul-07-17 05:38PM  Needelman Asset Management Inc Buys NCR Corp, Sells Teva Pharmaceutical Industries GuruFocus.com
12:47PM  [$$] U.K. Court Says Generics Infringe on Lilly's Alimta Patents The Wall Street Journal
01:09AM  [$$] Maryland Sued by Generic-Drug Trade Group Over New Pricing Law The Wall Street Journal
Jul-06-17 04:50PM  [$$] Maryland Sued by Generic-Drug Trade Group Over New Pricing Law The Wall Street Journal
03:41PM  4 Reasons Teva Pharmaceutical Industries Ltd. Gained 21% in June Motley Fool
10:06AM  VIVUS Settles with Teva on Weight Management Drug Generic Zacks
Jul-05-17 01:46PM  Options say this pharma name could break out CNBC Videos
Jul-04-17 07:38AM  United Therapeutics Orenitram May Show Revenue Growth in 2017 Market Realist
Jul-03-17 03:11PM  3 Top High-Yield Pharmaceutical Stocks to Buy Now Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Merck, Sanofi, Roche, Esperion and Teva Zacks
09:10AM  How Is United Therapeutics Remodulin Positioned in 2017? Market Realist
Jun-30-17 05:21PM  Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing TheStreet.com
12:04PM  Teva's (TEVA) Filing for Biosimilar Rituxan Accepted by FDA Zacks
Jun-29-17 01:31PM  iQ100 index up 20% for one year CNBC Videos
08:30AM  Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Rituxan® (rituximab) Business Wire
08:00AM  Teva Announces Publication of AIM-TD Study Results in The Lancet Psychiatry for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia Business Wire
Jun-28-17 03:07PM  Today's iQ100 leaders CNBC Videos
08:24AM  Teva/Xenon Nerve Pain Candidate Fails in Phase II Study Zacks
01:04AM  World's largest generic drugmaker warns health-care industry faces 'huge disruption' CNBC
Jun-27-17 09:16PM  Teva Pharma CEO on health-care bill and disruption CNBC Videos
04:08PM  This Biotech Crashed 28% Despite Positive Migraine Drug Tests Investor's Business Daily
02:02PM  Valeant: Out of the Frying Pan, Into the Fire Barrons.com
08:51AM  UPDATED: Xenon and Teva say mid-stage nerve pain drug missed primary, secondary endpoints MarketWatch
08:45AM  Short Sellers Run for Cover From Major Pharma 24/7 Wall St.
08:15AM  Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint GlobeNewswire
Jun-26-17 02:38PM  iQ100 up over twenty percent this year CNBC Videos
02:17PM  Valeant Pharma: A Debt Swap? Barrons.com
09:15AM  Allergan Continues to Focus on Acquisitions and Branded Unit Zacks
05:00AM  What You Don't Know About Generic Drugs, and How It Can Hurt You Bloomberg
Jun-25-17 09:42AM  These 3 Stocks Are Up Over 500% in the Last 3 Years Motley Fool
Jun-24-17 10:01AM  Facebook, Baidu, Coach And 5 Other Blue-Chip Stocks To Buy For Second-Half 2017 Forbes
Jun-23-17 08:00AM  Today's Research Reports on Stocks to Watch: Geron Corporation and Teva Pharmaceutical Accesswire
Jun-22-17 10:06AM  Glaxo's (GSK) Shingles Candidate Phase III Data Positive Zacks
Jun-21-17 06:41PM  GSK wins $235 million from Teva in Coreg patent trial Reuters
07:25AM  Israeli credit card firm Isracard names outgoing Teva CFO as chairman Reuters
Jun-20-17 03:18PM  ETFs with exposure to Teva Pharmaceutical Industries Ltd. : June 20, 2017 Capital Cube
02:06PM  Dupixent May Prove Effective in Multiple Diseases Market Realist
12:20PM  Label Expansion May Boost Regenerons Dupixent in the Future Market Realist
08:04AM  Should Investors Steer Clear of Opioid Drug Stocks? Motley Fool
Jun-19-17 01:47PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Isnt Healed by Paulsons Presence InvestorPlace
11:52AM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian? InvestorPlace
11:47AM  Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
Jun-16-17 09:33AM  Teva Pharmaceuticals Upgraded at Mizuho TheStreet.com
08:07AM  3 Dividend Stocks in Healthcare Motley Fool
Jun-15-17 12:54PM  Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
Jun-14-17 08:58PM  States Launch Bipartisan Probe of Opioid Marketing and Addiction The Wall Street Journal
Jun-13-17 12:07PM  Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space TheStreet.com
08:00AM  Today's Research Reports on Stocks to Watch: Celgene and Teva Pharmaceutical Industries Accesswire
07:55AM  Teva launches generic version of Merck cholesterol-lowering medicine American City Business Journals
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.